NCT00964002View on ClinicalTrials.gov

Efavirenz in Treating Patients With Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

September 19, 2011

Study Completion Date

April 8, 2014

Conditions
Prostate Cancer
Interventions
DRUG

efavirenz

Trial Locations (1)

33076

Institut Bergonie, Bordeaux

Sponsors

Lead Sponsor

Institut Bergonié
All Listed Sponsors
lead

Institut Bergonié

OTHER